| 查看: 2376 | 回复: 23 | |||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | |||
[交流]
帮我分析分析是否中稿呢
|
|||
|
前段时间在IOP上投了篇文章,编辑回复如下: Thank you for your submission which will be considered for publication in *************. The reference number for your article is ********. Please quote this number in all future correspondence regarding this article. 还让填一份assignment of copyright ASSIGNMENT OF COPYRIGHT and DECLARATION OF RESPONSIBILITY 1. IOP Publishing Ltd ("the Publisher" agrees to publishManuscript title: ********************* ("The Article" written by Names of all Authors: ****************************("the Named Authors" ![]() in the following journal: **********************("the Journal" ![]() 2. Transfer of Copyright Agreement 2.1 On acceptance for publication the undersigned author(s) (“Author”) of the Article assigns exclusively to IOP worldwide copyright in the Article for the full term and for all media and formats in all material published as part of the Article, which expression includes but is not limited to the text, abstract, tables, figures and graphs, but excludes any supplementary material. 2.2 If any of the Named Authors are Government employees, on acceptance for publication the Author shall grant IOP a royalty free exclusive licence for the full term of copyright for all media and formats to do in relation to the Article all acts restricted by copyright worldwide. 2.3 On acceptance for publication the Author shall grant IOP a royalty free non-exclusive licence for the full term of copyright for all media and formats to do in relation to any supplementary material deemed to be part of the Article all acts restricted by copyright worldwide. 3. Author Rights 3.1 IOP grants the Named Authors the rights specified in 3.2 and 3.3. All such rights must be exercised for non-commercial purposes, if possible should display citation information and IOP’s copyright notice, and for electronic use best efforts must be made to include a link to the on-line abstract in the Journal. Exercise of the rights in 3.3 additionally must not use the final published IOP format but the Named Author’s own format (which may include amendments made following peer review). 3.2 The rights are: 3.2.1 To make copies of the Article (all or part) for teaching purposes; 3.2.2 To include the Article (all or part) in a research thesis or dissertation; 3.2.3 To make oral presentation of the Article (all or part) and to include a summary and/or highlights of it in papers distributed at such presentations or in conference proceedings; and 3.2.4 All proprietary rights other than copyright. 3.3 The additional rights are to: 3.3.1 Use the Article (all or part) without modification in personal compilations or publications of a Named Author’s own works (provided not created by third party publisher); 3.3.2 Include the Article (all or part) on a Named Author’s own personal web site; 3.3.3 Include the Article (all or part) on web sites of the Institution (including its repository) where a Named Author worked when research for the Article was carried out; and 3.3.4 Include the Article (all or part) on third party web sites including e-print servers, but not on other publisher’s web sites. Signature In signing this Agreement the Author represents and warrants that the Article is the original work of the Named Authors, it has not been published previously in any form (other than as permitted under clause 3.2.2 which fact has been notified to IOP in writing), all Named Authors have participated sufficiently in the conception and writing of the Article, have received the final version of the Article, agree to its submission and take responsibility for it, and submission has been approved as necessary by the authorities at the establishment where the research was carried out. The Author warrants that he/she signs this Agreement as authorised agent for all Named Authors and has the full power to enter into this Agreement and to make the grants it contains, that the Article has not been and will not be submitted to another publisher prior to withdrawal or rejection, it does not infringe any third party rights, it contains nothing libellous or unlawful, all factual statements are to the best of the Author’s knowledge true or based on valid research conducted according to accepted norms, and all required permissions have been obtained in writing. All Named Authors assert their moral rights. Author’s signature………………………………………....………….Date…………………… Signature on behalf of Institution………………………………………Date……………………. |
» 猜你喜欢
退学或坚持读
已经有25人回复
遇见不省心的家人很难过
已经有13人回复
博士延得我,科研能力直往上蹿
已经有4人回复
免疫学博士有名额,速联系
已经有14人回复
面上基金申报没有其他的参与者成吗
已经有4人回复
多组分精馏求助
已经有6人回复
» 本主题相关价值贴推荐,对您同样有帮助:
请大家帮我分析这个产物能不能过柱纯化呢?
已经有27人回复
麻烦大家帮我分析分析
已经有4人回复
各位大牛,帮我分析下出国公派读博,是不是离我越来越远了?
已经有27人回复
大家帮我分析下导师的答复,是不是没有什么希望,谢谢大家了!!!
已经有5人回复
这个导师是什么意思呢,大家帮我分析一下吧。
已经有46人回复
哪位高手帮我分析这张幅循环伏安曲线呢
已经有12人回复
北京和深圳,哪个好呢?请大家帮我分析下
已经有28人回复
大家帮我分析分析
已经有4人回复
【求助】大家来帮我分析下是不是要这么久
已经有14人回复
大家帮我分析一下有没有这种可能呢?谢谢
已经有13人回复
» 抢金币啦!回帖就可以得到:
中国石油大学(华东)吴传德教授团队(国家杰青)2026硕、博招生
+2/270
诚招化工、有机、高分子等领域博士后及科研助理
+2/138
深圳大学信息功能电子材料方向“申请-考核制”博士生招生
+2/82
中国海洋大学与中国水产科学研究院 联合培养 专硕 食品加工与安全
+1/76
非粮生物质能技术全国重点实验室合成生物学创新团队全球招聘博士/博士后
+1/74
结构动力学与结构健康监测方向欧盟玛丽居里全奖博士招聘
+1/66
香港科技大学计算物理及流体力学课题组招收全奖博士后及博士生(2026年9月入学)
+1/36
山东科技大学招聘化学化工博士博士后
+1/31
中科院深圳先进院-免疫治疗方向-招收1名博士生(26年9月入学)
+1/15
中科院深圳先进院-免疫治疗方向-招收1名博士生(26年9月入学)
+1/15
联合研究团队招聘博后等青年人才
+1/9
上海理工大学顾敏院士、张轶楠教授团队 招聘 2026级 光学工程 博士生
+1/7
苏州大学招收申请考核制博士生、博士后(2026)
+1/6
《中文期刊点评》这个模块,怎么不能点评期刊了呢自动跳转到主页了
+1/5
电子科技大学 电子科学与工程学院 杨青慧教授 2026年招博士研究生数名
+1/5
【博士后/科研助理招聘-北京理工大学-集成电路与电子学院-国家杰青团队】
+1/4
华南理工大学宋波教授联合唐本忠院士招聘化学和材料方向博士后(长期有效)
+1/3
英国兰卡斯特大学(Lancaster University)大模型、计算机视觉PhD招生
+1/3
澳科大诚招2026年秋季全奖博士研究生(药剂学/生物材料方向)
+1/1
海南大学生态学博士点招收2026年博士研究生(第二批)
+1/1
19楼2011-04-01 09:17:31
2楼2011-03-31 15:48:33
3楼2011-03-31 16:13:08
4楼2011-03-31 16:19:31













agrees to publish
回复此楼
